• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
Earlier today
Yesterday
In the last 7 days
Gilead Sciences to Present at Upcoming Investor Conferences Gilead Sciences (Press Release)16:10 20-Feb-24
In the last month
Gilead signs antibody deal with Biocytogen amid ADC buzz Pharmaceutical Technology11:39 19-Feb-24
Dragonfly and Gilead enter partnership for cancer therapy Pharmaceutical Technology06:01 16-Feb-24
Gilead plans $4.3 billion deal to advance liver portfolio European Pharmaceutical Review14:30 14-Feb-24
Gilead opens new inflammatory diseases research centre Pharmaceutical Field08:51 14-Feb-24
Gilead Sciences Acquire CymaBay Therapeutics for $4.3 Billion European Pharmaceutical Manufacturer04:55 13-Feb-24
Gilead to Acquire CymaBay for $4.3B, Adding to Liver Portfolio Genetic Engineering and Biotechnology News16:33 12-Feb-24
Gilead to acquire CymaBay for $4.3 billion Investing.com10:59 12-Feb-24
FDA puts Gilead’s magrolimab trials on clinical hold Clinical Trials Arena04:14 8-Feb-24
Why Gilead Sciences Stock Dropped Today The Motley Fool15:56 7-Feb-24
Gilead Sciences posts $5.61bn net income in FY 2023 Pharmaceutical Technology06:55 7-Feb-24
AHF Hammers Gilead Over Continued Profiteering Business Wire (Press Release)19:26 6-Feb-24
Ted Love, MD, Joins Gilead Sciences’ Board of Directors Gilead Sciences (Press Release)16:38 1-Feb-24
Arcus rises, Gilead slips on expanded agreement Proactive Investors (US)09:59 30-Jan-24
Gilead and Arcus Biosciences expand oncology partnership deal Pharmaceutical Technology04:47 30-Jan-24
view more headlines
27 Feb 10:13

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.